|
Market Closed -
Nasdaq
07:00:00 08/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 1.000 USD | -3.85% |
|
-2.91% | -25.93% |
| 14/09 | Ocugen Insider Sold Shares Worth $589,110, According to a Recent SEC Filing | MT |
| 01/09 | Ocugen Doses First Patient in Trial of Potential Eye Disease Drug | MT |
| Market Cap | 339M 303M 283M 257M 484M 32.8B 487M 3.4B 1.33B 16.68B 1.27B 1.25B 53.63B | P/E 2026 * |
-3.87x | P/E 2027 * | -3.7x |
|---|---|---|---|---|---|
| Enterprise Value | 273M 243M 227M 206M 389M 26.36B 392M 2.73B 1.07B 13.41B 1.02B 1B 43.1B | EV / Sales 2026 * |
55x | EV / Sales 2027 * | 61.7x |
| Free-Float |
98.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCGN | Delayed | |
CBOE
| OCGN | Real-time | |
|
Boerse Muenchen
| 2H51 | Real-time | |
|
Tradegate
| 2H51 | Real-time | |
|
Börse Stuttgart
| 2H51 | Delayed | |
|
Mexican S.E.
| OCGN * | End-of-day quote | |
|
Deutsche Boerse AG
| 2H51 | Delayed |
Last Transcript: Ocugen, Inc.
| 1 day | -3.85% | ||
| 1 week | -2.91% | ||
| Current month | -2.91% | ||
| 1 month | -26.47% | ||
| 3 months | -33.33% | ||
| 6 months | -42.53% | ||
| Current year | -25.93% |
| 1 week | 1 |  | 1.12 |
| 1 month | 0.97 | | 1.32 |
| Current year | 0.97 | | 2.72 |
| 1 year | 0.97 | | 2.72 |
| 3 years | 0.34 | | 2.72 |
| 5 years | 0.34 | | 17.65 |
| 10 years | 0.17 | | 18.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 62 | 27/09/2019 |
| Director of Finance/CFO | - | 09/02/2026 | |
Paul Staid
COO | Chief Operating Officer | - | 01/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Shankar Musunuri
CHM | Chairman | 62 | 27/09/2019 |
Uday Kompella
BRD | Director/Board Member | 59 | 01/09/2013 |
Junge Zhang
BRD | Director/Board Member | 59 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/9/26 | Sell | Chief Executive Officer | -525,991 | 0.1551% | ||
| 1/4/26 | Exercice | Director | 388,268 | 0.1184% | ||
| 4/3/26 | Other | Chief Financial Officer | 1,250,350 | 0.3813% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.85% | -2.91% | -43.18% | +145.70% | 339M | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.68B | |
| -15.45% | -15.78% | +3.14% | +51.78% | 58.7B | |
| -1.21% | +1.64% | +4.59% | +32.82% | 48.36B | |
| +0.50% | -2.14% | +331.33% | +702.20% | 43.05B | |
| -0.72% | -3.99% | +28.50% | +29.94% | 42.48B | |
| +0.34% | -0.52% | +6.56% | +109.35% | 41.39B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.29B | |
| -0.50% | -3.10% | -10.19% | -14.35% | 23.93B | |
| -3.32% | -10.86% | -37.32% | +316.28% | 22.22B | |
| Average | -2.02% | -2.25% | +34.20% | +152.05% | 38.64B | |
| Weighted average by Cap. | -1.92% | -1.57% | +49.27% | +145.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.96M 4.43M 4.13M 3.75M 7.07M 480M 7.12M 49.66M 19.4M 244M 18.61M 18.21M 784M | 5.5M 4.91M 4.58M 4.16M 7.84M 532M 7.9M 55.1M 21.52M 271M 20.65M 20.2M 870M |
| Net income | -86.69M -77.46M -72.27M -65.64M -124M -8.39B -125M -868M -339M -4.26B -325M -318M -13.71B | -94.65M -84.57M -78.9M -71.67M -135M -9.16B -136M -948M -370M -4.66B -355M -348M -14.97B |
| Net Debt | -66.6M -59.51M -55.52M -50.43M -94.97M -6.44B -95.68M -667M -261M -3.28B -250M -245M -10.53B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | USD 1.000 | -3.85% | 5,221,078 |
| 06/10/26 | USD 1.040 | 0.00% | 5,293,892 |
| 05/10/26 | USD 1.040 | +1.96% | 5,495,756 |
| 02/10/26 | USD 1.020 | +2.00% | 3,446,560 |
| 01/10/26 | USD 1.000 | -2.91% | 5,058,462 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCGN Stock
Select your edition
All financial news and data tailored to specific country editions
